Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Age and aging in blood disorders: multiple myeloma | Synapse

July 1, 2014Open Access

Age and aging in blood disorders: multiple myeloma

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Do new standards of care incorporating immunomodulatory agents and proteasome inhibitors benefit all elderly patients with

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Zweegman et al. (Tue,) studied this question.

synapsesocial.com/papers/69fefaba413f0c047f2d5a34 https://doi.org/https://doi.org/10.3324/haematol.2014.110296

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow2013 · 230 citations
2Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial2009 · 381 citations
3Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: The diagnostic interface2007 · 91 citations
4A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age‐ and sex‐related differences2003 · 74 citations
5Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment2012 · 72 citations